Elevated novel inflammatory markers in heart failure patients are associated with increased risk of adverse outcomes within one year: insights from a longitudinal study

This study demonstrate that several novel inflammatory markers are strongly associated with adverse one-year outcomes in HF patients. Comparative analysis revealed that SIRI provides the most robust predictive performance, highlighting its potential as a valuable clinical tool for monitoring and risk stratification in HF management.